Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32513 total
FIVN delivered its August 6 earnings beat and the market responded decisively — a 20% jump on the day capping a 24% weekly gain — leaving the post-print story squarely about what shorts do next after being badly wrong…
Tandem Diabetes Care delivered one of the week's more dramatic squeeze setups — a heavily shorted stock that jumped 19% in a single session after earnings, leaving nearly 19% of the float still betting against it. The…
HA Sustainable Infrastructure Capital delivered a sharp earnings-driven rally this week, jumping 6.4% on August 7 and 7.4% for the week to close at $40.68 — yet short sellers have barely flinched, leaving a meaningful…
Zoetis delivered Q2 numbers that beat organic revenue expectations yet sent the stock down another 6% on the week — the contradiction between reported results and market reaction is the clearest signal of how…
Par Pacific Holdings enters the post-earnings stretch in a brutally different position than it occupied just one week ago — down 23% on the week to $66.29, after Q2 results landed well below the bullish setup the…
EPAM Systems enters the post-earnings stretch with a bruised share price, a wave of target cuts, and options traders turning notably more bullish — creating one of the more interesting cross-signal setups in IT…
Targa Resources Corp. delivered its Q2 results on August 6 and promptly sold off — yet the analyst community responded not with downgrades but with higher price targets, creating an immediate tension between the…
CorMedix reports its next earnings event on August 13, and the setup is defined by one uncomfortable tension: short sellers have built a substantial position in a stock down 16% over the past month, yet options traders…
Pilgrim's Pride is trading at $27.45 after an 8.6% one-day drop on July 30 — the Q2 earnings result delivered exactly the downside the defensively-positioned options market had been pricing in. The earnings reaction…
Dana Incorporated heads into the back half of 2026 having just printed a mild earnings beat, with the stock up nearly 6% on the week — but a diverging set of analyst moves published Friday tells a more complicated…
Genpact reported Q2 results on August 7 and the stock immediately punished the print, falling 5.2% on the day to $34.29 — reversing much of the month-long rally that had carried it up 15% into the release. The…
Celsius Holdings delivered its Q2 results on August 6, and the Street's reaction tells the whole story: every major firm kept its buy-equivalent rating and cut its price target sharply — a combination that captures the…
Energy Transfer LP enters the back half of the week down 2.6% on the day and 1.1% on the week — a modest reversal after the Q2 print — while options traders have turned measurably more cautious than at any point in…
CF Industries exits its Q2 earnings week nursing a sharp pullback, with the stock down 8.7% on the week to $114.35 — a move that has widened the gap to consensus price targets and prompted the first notable post-print…
RBC Bearings has cleared its fiscal Q1 print and the analyst desk wasted no time responding — the question now is whether the stock can close the gap to a consensus target that remains well above the current price. The…
Tenaris enters the week after its August 5 earnings print down 7.2% — the steepest weekly decline in the peer group — as the market digests a result that left valuation multiples noticeably cheaper but the borrow…
Herbalife enters the back half of 2026 with a striking contradiction at its core: options traders turned sharply bullish this week, just days after the stock fell more than 10% on disappointing Q2 results. The options…
Texas Roadhouse just delivered its Q2 print — and the post-earnings setup looks markedly different from the bullish pre-report positioning that dominated this time last week. The sharpest shift is in options. The…
Halozyme Therapeutics delivered a jolt to the market this week — a 23% single-day move on August 7 following strong Q2 results, leaving a meaningful short position scrambling and analysts rushing to lift targets…
Somnigroup International has printed its Q2 results and the market's verdict was swift: the stock fell 6.2% on August 6, confirming the cautious pre-earnings positioning documented in last week's note, and the Street…
